These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 25739189)

  • 41. Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy.
    Boehm BO; Lang GK; Jehle PM; Feldman B; Lang GE
    Horm Metab Res; 2001 May; 33(5):300-6. PubMed ID: 11440277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
    Wilczyński M; Dzivgielewski K
    Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electrofunctional investigations of the optic nerve in diabetes.
    Steindler P
    Metab Pediatr Syst Ophthalmol (1985); 1986; 9(2-4):74-6. PubMed ID: 3452011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Oscillatory potentials in electroretinographic evaluation of retinal function in insulin-dependent diabetics without retinopathy].
    Lubiński W; Barnyk K; Penkala K; Sych Z; Andrysiak-Mamos E; Archimowicz-Cyrylowska B; Machoy E; Palacz O
    Klin Oczna; 1999; 101(4):249-52. PubMed ID: 10581890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema.
    Krepler K; Biowski R; Schrey S; Jandrasits K; Wedrich A
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):735-8. PubMed ID: 12271370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retinal micropseudocysts in diabetic retinopathy: prospective functional and anatomic evaluation.
    Forte R; Cennamo G; Finelli ML; Bonavolontà P; Greco GM; de Crecchio G
    Ophthalmic Res; 2012; 48(1):6-11. PubMed ID: 22205346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical efficacy of eiconol in patients with diabetic retinopathy].
    Sorokin EL; Smoliakova GP; Bachaldin IL
    Vestn Oftalmol; 1997; 113(4):37-9. PubMed ID: 9381643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Visual evoked potentials in diabetics].
    Bártek L; Gat'ková A; Rybka J; Kalita Z; Smecka Z
    Cesk Oftalmol; 1989 May; 45(3):192-6. PubMed ID: 2743440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Visual evoked potentials after photostress in newly diagnosed insulin-dependent diabetes patients.
    Parisi V; Uccioli L; Monticone G; Parisi L; Durola L; Pernini C; Neuschuler R; Menzinger G; Bucci MG
    Graefes Arch Clin Exp Ophthalmol; 1995 Oct; 233(10):601-4. PubMed ID: 8529901
    [No Abstract]   [Full Text] [Related]  

  • 52. A simple atomizer system for application of chemicals in electrophysiological experiments on neurons of the isolated retina.
    Djamgoz MB
    J Neurosci Methods; 1983 May; 8(1):87-94. PubMed ID: 6135825
    [No Abstract]   [Full Text] [Related]  

  • 53. Diabetic retinopathy: how far are we from personalized medicine?
    Sahajpal NS; Chaubey A; Goel RK; Jain SK
    Future Med Chem; 2018 Oct; 10(19):2249-2252. PubMed ID: 30215275
    [No Abstract]   [Full Text] [Related]  

  • 54. Visual evoked potentials after photostress in insulin-dependent diabetic patients with or without retinopathy.
    Parisi V; Uccioli L; Monticone G; Parisi L; Menzinger G; Bucci MG
    Graefes Arch Clin Exp Ophthalmol; 1994 Apr; 232(4):193-8. PubMed ID: 8034206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bimoclomol improves early electrophysiological signs of retinopathy in diabetic rats.
    Bíró K; Pálhalmi J; Tóth AJ; Kukorelli T; Juhász G
    Neuroreport; 1998 Jun; 9(9):2029-33. PubMed ID: 9674588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrophysiological evaluation of the macular cone adaptation: VEP after photostress. A review.
    Parisi V
    Doc Ophthalmol; 2001 May; 102(3):251-62. PubMed ID: 11556488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Using deltalicin for the treatment of patients with diabetic retinopathy].
    Kresiun NV; Godlevskiĭ LS
    Eksp Klin Farmakol; 2014; 77(12):22-5. PubMed ID: 25739189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of deltalycyn and transcranial cerebellar stimulation upon recovery of retina after photo stress in patients with diabetic retinopathy.
    Kresyun NV
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):1068-73. PubMed ID: 25581971
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.